methyl 2-(5-methoxy-2-methyl-1H-indol-3-yl)-2-oxoacetate | 19414-86-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: methyl 2-(5-methoxy-2-methyl-1H-indol-3-yl)-2-oxoacetate
• CAS: 19414-86-9
• 化学式: C₁₃H₁₃NO₄
• 分子量: 247.251
• InChiKey: CRMPJPNMYWZNMF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  18
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.23
• 拓扑面积：
  68.4
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  methyl 2-(5-methoxy-2-methyl-1H-indol-3-yl)-2-oxoacetate 在 lithium aluminium tetrahydride 、 氨 作用下， 以 四氢呋喃 、 水 为溶剂， 反应 34.0h， 生成 5-methoxy-2-methyltryptamine
  参考文献：
  名称：

  Virtual screening-driven discovery of dual 5-HT6/5-HT2A receptor ligands with pro-cognitive properties

  摘要：

  A virtual screening campaign aimed at finding structurally new compounds active at 5-HT6R provided a set of candidates. Among those, one structure, 4-(5-{[(2-{5-fluoro-1H-pyrrolo[2,3-b]pyridin-3-yl}ethyl) amino]methyl}furan-2-yl)phenol (1, 5-HT6R K-i = 91 nM), was selected as a hit for further optimization. As expected, the chemical scaffold of selected compound was significantly different from all the serotonin receptor ligands published to date. Synthetic efforts, supported by molecular modelling, provided 43 compounds representing different substitution patterns. The derivative 42, 4-(5-{[(2-{5-fluoro-1H-pyrrolo[2,3-b]pyridin-3-yl}ethyl)amino]methyl}furan-2-yl)phenol (5-HT6R K-j= 25, 5-HT2AR K-i = 32 nM), was selected as a lead and showed a good brain/plasma concentration profile, and it reversed phencyclidine-induced memory impairment. Considering the unique activity profile, the obtained series might be a good starting point for the development of a novel antipsychotic or antidepressant with procognitive properties. (C) 2019 The Authors. Published by Elsevier Masson SAS.

  DOI：

  10.1016/j.ejmech.2019.111857
• 作为产物：
  描述：

  5-甲氧基-2-甲基吲哚 以 乙醚 为溶剂， 反应 6.0h， 生成 methyl 2-(5-methoxy-2-methyl-1H-indol-3-yl)-2-oxoacetate
  参考文献：
  名称：

  铜（I）催化2-取代的三苯酚与芳基鎓盐的级联脱芳香化

  摘要：

  在随后的环化反应中，实现了铜（I）催化的2-取代的三苯酚的脱芳基芳基化和乙烯基化。级联脱芳香化序列提供了具有两个季碳中心的多用途呋喃二氢吲哚衍生物，收率好至极好。

  DOI：

  10.1021/ol301939w

文献信息

• [EN] FAAH INHIBITORS<br/>[FR] INHIBITEURS DE FAAH
  申请人：IRONWOOD PHARMACEUTICALS INC

  公开号：WO2012088469A1

  公开（公告）日：2012-06-28

  The present disclosure relates to compounds useful as inhibitors of the enzyme Fatty Acid Amide Hydrolase (FAAH). The disclosure also provides pharmaceutically acceptable compositions comprising the compounds of the disclosure and methods of using the compositions in the treatment or prevention of various disorders. Compounds of the invention are described in Table 1.

  本公开涉及作为脂肪酰胺水解酶（FAAH）抑制剂有用的化合物。该公开还提供包括本公开化合物的药学上可接受的组合物，以及使用这些组合物在治疗或预防各种疾病中的方法。发明的化合物在表1中描述。
• Copper-catalyzed carbonylative transformations of indoles with hexaketocyclohexane
  作者：Zechao Wang、Zhiping Yin、Xiao-Feng Wu

  DOI：10.1039/c8cc01784k

  日期：——

  With hexaketocyclohexane octahydrate as the carbon monoxide source, a novel procedure for copper-catalyzed direct double carbonylation of indoles has been established. Using alcohols as reaction partners, moderate to good yields of the desired double carbonylation products have been obtained. Wide functional group tolerance and substrate scope can be observed.

  以六酮环己烷八水合物为一氧化碳源，建立了铜催化的吲哚直接双羰基化的新方法。使用醇作为反应伙伴，已获得中等至良好产率的所需双羰基化产物。可以观察到宽泛的官能团耐受性和底物范围。
• FAAH Inhibitors
  申请人：Hudson Colleen

  公开号：US20150175599A1

  公开（公告）日：2015-06-25

  The present disclosure relates to compounds useful as inhibitors of the enzyme Fatty Acid Amide Hydrolase (FAAH). The disclosure also provides pharmaceutically acceptable compositions comprising the compounds of the disclosure and methods of using the compositions in the treatment or prevention of various disorders. Compounds of the invention are described in Table 1.

  本公开涉及一种作为脂肪酸酰胺水解酶（FAAH）抑制剂有用的化合物。本公开还提供了包含本公开化合物的药学上可接受的组合物，以及使用这些组合物在治疗或预防各种疾病的方法。发明的化合物在表1中描述。
• FAAH INHIBITORS
  申请人：Ironwood Pharmaceuticals, Inc.

  公开号：EP2655356A1

  公开（公告）日：2013-10-30
• US9657012B2
  申请人：——

  公开号：US9657012B2

  公开（公告）日：2017-05-23